Companion care

Stopping a GLP-1: off-ramp and follow-up questions

Prepare for a clinician-led GLP-1 pause or discontinuation: understand weight-regain evidence, care continuity, costs and claims about off-ramp programs.

Published Updated 4 min readEditorial policy

About this guide

Editorial review

no named editorial reviewer recorded

Medical review

not medically reviewed

Review focus

Clinician review needed

Content updated October 18, 2026

This guide is for general education and comparison planning. It does not provide medical advice. Review the sources (3) and talk with a licensed clinician about your situation. The content update label is not a medical-review date.

Source links let you check the references; they do not establish that every claim has been independently verified. This guide has no named editorial reviewer recorded. Topic-based review flags identify where additional expertise is needed, not completed reviews.

A named clinician reviewer is still needed before this page should be treated as clinically reviewed. This page still should not be treated as legal, insurance, privacy, or financial advice.

Some content may be drafted with automated tools and then edited for clarity and sourcing. We do not claim clinician review unless a page explicitly names a reviewer.

An off-ramp is a care conversation, not a universal schedule

People consider stopping or pausing treatment for different reasons, including tolerability, access, cost or a change in goals. Those reasons deserve a conversation with the prescribing clinician. The term off-ramp does not define a clinically validated protocol that fits everyone. This guide offers preparation questions, not tapering, dose-spacing, switching or restart instructions. Your clinician needs to consider what the medication treats and the rest of your care.

  • Contact your prescribing team before a planned change; explain whether the issue is cost, access, tolerability or another concern.
  • Ask for written instructions appropriate to your actual prescription and circumstances.
  • If you have already stopped or missed treatment, tell the team rather than using a generic online restart plan.

What the withdrawal studies can tell you

Weight regain after stopping is a real possibility. In the STEP 1 extension, participants regained about two-thirds of their previous weight loss on average during the year after semaglutide and the trial lifestyle intervention ended. The extension was exploratory and included 327 participants. SURMOUNT-4 separately found greater regain after tirzepatide withdrawal than with continued treatment. These studies support planning follow-up; neither tested a commercial off-ramp package or established an individual's future result.

  • Trial averages are not a personal forecast or a judgment about effort.
  • Different medications, study populations and follow-up periods should not be treated as interchangeable.
  • A program must provide its own evidence for any claim that it prevents regain.

Make the handoff explicit

Before a membership ends, establish who remains responsible for care. A dietitian or coach may help with nutrition and routines, but that does not transfer prescribing responsibility. If the medication is used for diabetes or another condition, discuss the implications with the clinician managing that condition. Arrange access to records before an account closes. Keep those records within the care team; you do not need to submit them to this site.

  • Who should receive my medication list, recent clinical notes and relevant test results?
  • Who will answer questions after cancellation, and when does that access end?
  • If I move to another clinician, when is the first appointment and what happens before then?

Discuss what follow-up will look like

Ask the clinician which health changes matter in your circumstances, how to review them and when to meet again. The plan may address more than weight. Ask how to discuss appetite changes, daily function, distress around eating or changes in the condition being treated. Your team should explain when to contact them sooner. Do not wait for a routine visit if something feels urgent, and do not rely on a worksheet to assess symptoms.

  • What follow-up should be arranged before the program ends?
  • Which concerns go to the prescriber, a dietitian or another professional?
  • What written contact and escalation instructions should I keep?

Separate a coverage problem from a clinical decision

An insurance exclusion or unaffordable bill does not itself answer whether treatment should change. Ask the provider and insurer for the specific coverage issue, deadlines and available administrative options. Avoid canceling follow-up simply because medication payment is unresolved. If continuing through the same service is not possible, ask about a care handoff. No alternative treatment, lower-cost product or coverage outcome is guaranteed.

  • Request separate prices for follow-up visits, nutrition sessions, medication and any continuing membership.
  • Ask whether a canceled prescription also cancels clinical messaging or record access.
  • Use the existing coverage and records guides rather than assuming a new program can resolve every access issue.

How to assess an off-ramp program

Look for a precise description of services and responsibilities. Is it prescribing care, registered dietitian support, coaching or an app? Ask whether it coordinates with your existing clinician and can support people in your state. Be cautious about promises of permanent results, guaranteed freedom from medication or a proprietary schedule said to work for everyone. A program description is evidence of an advertised service, not proof that it prevents regain.

  • Ask for results specifically measured after discontinuation, including follow-up duration and participant numbers.
  • Check whether the result has a comparison group or is a testimonial or selected-user report.
  • Ask what happens if your needs change, including referral, re-evaluation and charges.

Prepare your next appointment

Use the care planner to choose questions about transition, costs, support and longer-term follow-up. Bring the sheet to the clinician who knows your treatment. Keep space for their instructions, the next appointment and a named contact. A useful plan remains flexible and can be reassessed. It should not promise that a particular weight, medication status or outcome can be maintained indefinitely.

Keep researching

Related GLP-1 care guides